82 related articles for article (PubMed ID: 20443276)
1. [Questionnaire survey on patients receiving scheduled inpatient chemotherapy clarifies the issues of outpatient chemotherapy for advanced or recurrent colorectal cancer].
Arakawa Y; Sakuyama T; Ichiba T; Inoue D; Kobayashi T; Aiba K
Gan To Kagaku Ryoho; 2007 Dec; 34 Suppl 2():245-7. PubMed ID: 20443276
[TBL] [Abstract][Full Text] [Related]
2. Advances in chemotherapy against advanced or metastatic colorectal cancer.
Omura K
Digestion; 2008; 77 Suppl 1():13-22. PubMed ID: 18204257
[TBL] [Abstract][Full Text] [Related]
3. Comparison between ambulatory infusion mode and inpatient infusion mode from the perspective of quality of life among colorectal cancer patients receiving chemotherapy.
Lee YM; Hung YK; Mo FK; Ho WM
Int J Nurs Pract; 2010 Oct; 16(5):508-16. PubMed ID: 20854349
[TBL] [Abstract][Full Text] [Related]
4. [Second-line chemotherapy for colorectal cancer].
Komatsu Y; Sogabe S; Kawamoto Y; Iwanaga I; Uehata Y; Yuki S; Asaka M
Gan To Kagaku Ryoho; 2009 May; 36(5):721-5. PubMed ID: 19461170
[TBL] [Abstract][Full Text] [Related]
5. [Outpatient chemotherapy of an advanced or metastatic colorectal cancer].
Sato T; Kokuba Y; Ozawa H; Hatate K; Nakamura T; Onosato W; Ihara A; Watanabe M
Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():257-9. PubMed ID: 17469353
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy for metastatic colorectal cancer].
Iwasa S; Shimada Y
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer.
Limat S; Bracco-Nolin CH; Legat-Fagnoni C; Chaigneau L; Stein U; Huchet B; Pivot X; Woronoff-Lemsi MC
Eur J Health Econ; 2006 Jun; 7(2):107-13. PubMed ID: 16474968
[TBL] [Abstract][Full Text] [Related]
8. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Kubota K
Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.
Viel E; Demarchi MF; Chaigneau L; Nguyen T; Legat C; Stein U; Thiery-Vuillemin A; Limat S; Pivot X; Borg C
Am J Clin Oncol; 2008 Feb; 31(1):89-94. PubMed ID: 18376234
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy prescription patterns in colon cancer: a patterns-of-care survey in New Zealand.
Thotathil ZS; Long JE; Kennedy I; Jameson MB; Adams J; Kuper M
N Z Med J; 2007 Jul; 120(1258):U2636. PubMed ID: 17653254
[TBL] [Abstract][Full Text] [Related]
11. [Development of taste disorders following FOLFOX-FOLFIRI therapy and its effects on the QOL of patients with colorectal cancer].
Takimoto N; Sugawara S; Iida A; Sakakibara T; Mori K; Sugiura M; Yamamura K; Adachi M
Gan To Kagaku Ryoho; 2009 Mar; 36(3):431-5. PubMed ID: 19295267
[TBL] [Abstract][Full Text] [Related]
12. [Team-based medical care can improve tailor made chemotherapy for colorectal cancer].
Muneoka K; Shirai Y; Sasaki M; Kanda J; Asakura T; Wakabayashi H; Toshima M; Hatakeyama K
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1883-7. PubMed ID: 19011336
[TBL] [Abstract][Full Text] [Related]
13. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy.
Lissoni P; Brivio F; Fumagalli L; Di Fede G; Brera G
In Vivo; 2005; 19(6):1077-80. PubMed ID: 16277025
[TBL] [Abstract][Full Text] [Related]
15. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
[TBL] [Abstract][Full Text] [Related]
16. [Clinical administration of FOLFOX regimens for patients with unresectable advanced or recurrent colorectal cancer].
Minami K; Kameda A; Tsutani Y; Suzuki T; Miyahara E; Noso Y
Gan To Kagaku Ryoho; 2007 Apr; 34(4):573-7. PubMed ID: 17431362
[TBL] [Abstract][Full Text] [Related]
17. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
Benoist S; Nordlinger B
Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
[TBL] [Abstract][Full Text] [Related]
18. Central venous access port-related complications in outpatient chemotherapy for colorectal cancer.
Inaba Y; Yamaura H; Sato Y; Najima M; Shimamoto H; Nishiofuku H; Ura T; Muro K
Jpn J Clin Oncol; 2007 Dec; 37(12):951-4. PubMed ID: 18057011
[TBL] [Abstract][Full Text] [Related]
19. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for operable and advanced colorectal cancer.
Aschele C; Bergamo F; Lonardi S
Cancer Treat Rev; 2009 Oct; 35(6):509-16. PubMed ID: 19481872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
